{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:41:00Z","timestamp":1790422860040,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-026-00762-y","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T03:45:07Z","timestamp":1774496707000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["MEF2A activates the ZDHHC20\/NF-\u03baB pathway to inhibit doxorubicin sensitivity and promote the malignant progression of acute myeloid leukemia"],"prefix":"10.1186","volume":"21","author":[{"given":"Xi","family":"Ming","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"762_CR1","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/ajh.26822","volume":"98","author":"S Shimony","year":"2023","unstructured":"Shimony S, Stahl M, Stone RM. Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol. 2023;98:502\u201326.","journal-title":"Am J Hematol"},{"key":"762_CR2","doi-asserted-by":"publisher","first-page":"101466","DOI":"10.1016\/j.beha.2023.101466","volume":"36","author":"G Magee","year":"2023","unstructured":"Magee G, Ragon BK. Allogeneic hematopoietic cell transplantation in acute myeloid leukemia. Best Pract Res Clin Haematol. 2023;36:101466.","journal-title":"Best Pract Res Clin Haematol"},{"key":"762_CR3","first-page":"46","volume":"75","author":"HM Kantarjian","year":"2025","unstructured":"Kantarjian HM, DiNardo CD, Kadia TM, Daver NG, Altman JK, Stein EM, et al. Acute myeloid leukemia management and research in 2025. CA Cancer J Clin. 2025;75:46\u201367.","journal-title":"CA Cancer J Clin"},{"key":"762_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.31557\/APJCP.2025.26.1.5","volume":"26","author":"SJ Sinha","year":"2025","unstructured":"Sinha SJ, Kumar B, Prasad CP, Chauhan SS, Kumar M. Emerging Research and Future Directions on Doxorubicin: A Snapshot. Asian Pac J Cancer Prev. 2025;26:5\u201315.","journal-title":"Asian Pac J Cancer Prev"},{"key":"762_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13045-017-0416-0","volume":"10","author":"H Hackl","year":"2017","unstructured":"Hackl H, Astanina K, Wieser R. Molecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemia. J Hematol Oncol. 2017;10:51.","journal-title":"J Hematol Oncol"},{"key":"762_CR6","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.18632\/oncotarget.6223","volume":"7","author":"JR Pon","year":"2016","unstructured":"Pon JR, Marra MA. MEF2 transcription factors: developmental regulators and emerging cancer genes. Oncotarget. 2016;7:2297\u2013312.","journal-title":"Oncotarget"},{"key":"762_CR7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1177\/10815589241290199","volume":"73","author":"C Chu","year":"2025","unstructured":"Chu C, Zhang Y, Yu R, Liu B, Wang B, Xu Z, et al. MEF2A restrains cisplatin resistance in gastric cancer cells by modulating NFKBIA\/NF-\u03baB signaling pathway. J Investig Med. 2025;73:54\u201366.","journal-title":"J Investig Med"},{"key":"762_CR8","doi-asserted-by":"publisher","first-page":"e70007","DOI":"10.1002\/kjm2.70007","volume":"41","author":"YH Hao","year":"2025","unstructured":"Hao YH, Yang CR, Shi WJ, Zhong XY. PSMD14 Transcriptionally Activated by MEF2A Promotes Pancreatic Cancer Development by Upregulating SPON2 Expression. Kaohsiung J Med Sci. 2025;41:e70007.","journal-title":"Kaohsiung J Med Sci"},{"key":"762_CR9","doi-asserted-by":"crossref","unstructured":"Wu K, Li Y, Nie B, Guo C, Ma X, Li L, et al. MEF2A is a transcription factor for circPVT1 and contributes to the malignancy of acute myeloid leukemia. Int J Oncol. 2024;65.","DOI":"10.3892\/ijo.2024.5699"},{"key":"762_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/1878-0261.13308","volume":"17","author":"B Zhou","year":"2023","unstructured":"Zhou B, Hao Q, Liang Y, Kong E. Protein palmitoylation in cancer: molecular functions and therapeutic potential. Mol Oncol. 2023;17:3\u201326.","journal-title":"Mol Oncol"},{"key":"762_CR11","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.7150\/ijbs.72244","volume":"18","author":"Z Liu","year":"2022","unstructured":"Liu Z, Xiao M, Mo Y, Wang H, Han Y, Zhao X, et al. Emerging roles of protein palmitoylation and its modifying enzymes in cancer cell signal transduction and cancer therapy. Int J Biol Sci. 2022;18:3447\u201357.","journal-title":"Int J Biol Sci"},{"key":"762_CR12","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.1038\/s41467-024-49105-3","volume":"15","author":"H Zhang","year":"2024","unstructured":"Zhang H, Sun Y, Wang Z, Huang X, Tang L, Jiang K, et al. ZDHHC20-mediated S-palmitoylation of YTHDF3 stabilizes MYC mRNA to promote pancreatic cancer progression. Nat Commun. 2024;15:4642.","journal-title":"Nat Commun"},{"key":"762_CR13","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s12943-024-02195-5","volume":"23","author":"Y Mo","year":"2024","unstructured":"Mo Y, Han Y, Chen Y, Fu C, Li Q, Liu Z, et al. ZDHHC20 mediated S-palmitoylation of fatty acid synthase (FASN) promotes hepatocarcinogenesis. Mol Cancer. 2024;23:274.","journal-title":"Mol Cancer"},{"key":"762_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M, et al. NF-\u03baB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target Ther. 2024;9:53.","journal-title":"Signal Transduct Target Ther"},{"key":"762_CR15","doi-asserted-by":"crossref","unstructured":"Di Francesco B, Verzella D, Capece D, Vecchiotti D, Di Vito Nolfi M, Flati I, et al. NF-\u03baB: A Druggable Target in Acute Myeloid Leukemia. Cancers (Basel). 2022;14.","DOI":"10.3390\/cancers14143557"},{"key":"762_CR16","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra1406184","volume":"373","author":"H D\u00f6hner","year":"2015","unstructured":"D\u00f6hner H, Weisdorf DJ, Bloomfield CD. Acute Myeloid Leukemia. N Engl J Med. 2015;373:1136\u201352.","journal-title":"N Engl J Med"},{"key":"762_CR17","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.2147\/OTT.S191621","volume":"12","author":"J Zhang","year":"2019","unstructured":"Zhang J, Gu Y, Chen B. Mechanisms of drug resistance in acute myeloid leukemia. Onco Targets Ther. 2019;12:1937\u201345.","journal-title":"Onco Targets Ther"},{"key":"762_CR18","doi-asserted-by":"crossref","unstructured":"Bergmann AK, Castellano G, Alten J, Ammerpohl O, Kolarova J, Nordlund J, et al. DNA methylation profiling of pediatric B-cell lymphoblastic leukemia with KMT2A rearrangement identifies hypomethylation at enhancer sites. Pediatr Blood Cancer. 2017;64.","DOI":"10.1002\/pbc.26251"},{"key":"762_CR19","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.3324\/haematol.2021.279542","volume":"107","author":"KK Madugula","year":"2022","unstructured":"Madugula KK, Joseph J, DeMarino C, Ginwala R, Teixeira V, Khan ZK, et al. Regulation of human T-cell leukemia virus type 1 antisense promoter by myocyte enhancer factor-2\u00a0C in the context of adult T-cell leukemia and lymphoma. Haematologica. 2022;107:2928\u201343.","journal-title":"Haematologica"},{"key":"762_CR20","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1038\/s41375-023-01953-6","volume":"37","author":"S Hou","year":"2023","unstructured":"Hou S, Wang X, Guo T, Lan Y, Yuan S, Yang S, et al. PHF6 maintains acute myeloid leukemia via regulating NF-\u03baB signaling pathway. Leukemia. 2023;37:1626\u201337.","journal-title":"Leukemia"},{"key":"762_CR21","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12964-023-01259-1","volume":"21","author":"K Otmani","year":"2023","unstructured":"Otmani K, Rouas R, Lagneaux L, Krayem M, Duvillier H, Berehab M, et al. Acute myeloid leukemia-derived exosomes deliver miR-24-3p to hinder the T-cell immune response through DENN\/MADD targeting in the NF-\u03baB signaling pathways. Cell Commun Signal. 2023;21:253.","journal-title":"Cell Commun Signal"},{"key":"762_CR22","doi-asserted-by":"publisher","first-page":"666","DOI":"10.4149\/neo_2013_085","volume":"60","author":"SV Mehta","year":"2013","unstructured":"Mehta SV, Shukla SN, Vora HH. Overexpression of Bcl2 protein predicts chemoresistance in acute myeloid leukemia: its correlation with FLT3. Neoplasma. 2013;60:666\u201375.","journal-title":"Neoplasma"},{"key":"762_CR23","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/cei.13522","volume":"203","author":"L Del Pino Molina","year":"2021","unstructured":"Del Pino Molina L, Torres Canizales JM, Pern\u00eda O, Rodr\u00edguez Pena R, Ibanez de Caceres I. L\u00f3pez Granados E. Defective Bcl-2 expression in memory B cells from common variable immunodeficiency patients. Clin Exp Immunol. 2021;203:341\u201350.","journal-title":"Clin Exp Immunol"},{"key":"762_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0304-3835(01)00834-5","volume":"180","author":"M Notarbartolo","year":"2002","unstructured":"Notarbartolo M, Cervello M, Dusonchet L, Cusimano A, D\u2019Alessandro N. Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel anti-apoptosis factors IAP (inhibitory of apoptosis proteins). Cancer Lett. 2002;180:91\u2013101.","journal-title":"Cancer Lett"},{"key":"762_CR25","doi-asserted-by":"publisher","first-page":"104161","DOI":"10.1016\/j.drudis.2024.104161","volume":"29","author":"Y Guo","year":"2024","unstructured":"Guo Y, Ashrafizadeh M, Tambuwala MM, Ren J, Orive G, Yu G. P-glycoprotein (P-gp)-driven cancer drug resistance: biological profile, non-coding RNAs, drugs and nanomodulators. Drug Discov Today. 2024;29:104161.","journal-title":"Drug Discov Today"},{"key":"762_CR26","doi-asserted-by":"publisher","first-page":"130753","DOI":"10.1016\/j.bbagen.2024.130753","volume":"1869","author":"Z Cai","year":"2025","unstructured":"Cai Z, Isaji T, Liang C, Fukuda T, Zhang D, Gu J. Fucosyltransferase 4 upregulates P-gp expression for chemoresistance via NF-\u03baB signaling pathway. Biochim Biophys Acta Gen Subj. 2025;1869:130753.","journal-title":"Biochim Biophys Acta Gen Subj"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00762-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00762-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00762-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:16:17Z","timestamp":1777940177000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13062-026-00762-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["762"],"URL":"https:\/\/doi.org\/10.1186\/s13062-026-00762-y","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"12 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval for this research was obtained from the Tongji Hospital\u2019s Ethics Committee prior to study initiation. It was performed in accordance with the Declaration of Helsinki. All animal procedures received prior approval from the Tongji Hospital\u2019s Animal Ethics Committee and performed in accordance with the guidelines of the National Animal Care and Ethics Institution.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"60"}}